Corporate Profile for Gilead Sciences, Inc., dated 9/1/95.--(BUSINESS WIRE)--The following Corporate Profile is available for inclusion in your files. News releases for this client are distributed by Business Wire and also become part of the leading databases and information services. These include Dow Jones News/Retrieval, Bloomberg Financial Markets, Reuter Company Newsyear, Reuter Business Briefing, DataTimes, Nexis, Dialog, NewsNet, America OnLine, CompuServe, Delphi, Individual's HeadsUp and First!, Desktop Data's NewsEdge, UMI Data Courier, NewsBank, Information Access Company and many others. -0- Published date: Sept. 1, 1995 Company name: Gilead Sciences, Inc.
Address: 353 Lakeside Drive
Foster City, CA 94404
Telephone No.: 415/574-3000 Chairman and President: Michael L. Riordan, M.D. Chief Financial Officer: Michael F. Bigham (Executive VP Operations) Investor Relations Contact: Lana Lauher Business number: 415/573-4858 Home number: -- Public Relations Contact: Lana Lauher Business number: 415/573-4858 Home number: -- Trading symbol: GILD Industry: Biotechnology Company description: Gilead Sciences, based in Foster City, California, is a leader in the discovery and development of a new class of human therapeutics based on nucleotides cyclic nucleotides those in which the phosphate group bonds to two atoms of the sugar forming a ring, as in cyclic AMP and cyclic GMP, which act as intracellular second messengers. nu·cle·o·tide (n  , the building blocks of DNA
and RNA. The Company's research and development efforts encompass
three interrelated programs: small molecule antivirals, cardiovascular
therapeutics and genetic code blockers for cancer and other diseases.
Gilead's expertise in each of these areas has also resulted in the
discovery of non-nucleotide product candidates that expand the
Company's technology platforms.Gilead's most advanced product under development is VISTIDE(TM) (cidofovir cidofovir /ci·dof·o·vir/ (si-dof´o-vir) an antiviral nucleoside analogue used in the treatment of cytomegalovirus CMV Any of a group of herpes viruses that attack and enlarge epithelial cells. Such viruses also cause a disease of infants characterized by circulatory dysfunction and microcephaly. Also called visceral disease virus. retinitis circina´ta , circinate retinitis circinate retinopathy. exudative retinitis see under retinopathy. retinitis pigmento´sa a group of diseases, often hereditary, marked by progressive loss of retinal response, retinal atrophy, attenuation of retinal vessels, clumping of pigment, and contraction of the visual field. in patients with acquired immunodeficiency syndrome. intravenous) for the treatment of cytomegalovirus (CMV CMV - Capitalized Manufacturing VariancesCMV - Casa Myrna Vazquez (Boston, Massachusetts domestic violence organization) CMV - Christelijke Motorrijders Vereniging CMV - Cisplatin, Methotrexate, Vinblastine (chemotherapy combination) CMV - Combat Mobility Vehicle CMV - Commercial Motor Vehicle CMV - Common Mode Voltage CMV - Controlled Medical Vocabularies CMV - Conventional Mechanical Ventilation CMV - Counter Mobility Vehicle) retinitis, a disease that if untreated can cause blindness in patients with AIDS. Gilead plans to file for approval to market VISTIDE in the U.S. by the end of 1995, followed by equivalent regulatory submissions in Europe. Gilead is also conducting human clinical studies of an intravitreous product for CMV retinitis and has product candidates in clinical studies for viral diseases caused by human immunodeficiency virus (HIV), human papillomavirus human papillomavirus (HPV) any of a number of species that cause warts, particularly plantar warts and genital warts, on the skin and mucous membranes in humans; some are associated with malignancies of the genital tract. Papillomavirus /Pa·pil·lo·ma·vi·rus/ (pap?i-lo´mah-vi?rus, herpes simplex herpes simplex (hûr`pēz), an acute viral infection of the skin characterized by one or more painful, itching blisters filled with clear fluid. virus and hepatitis B virus infection. Gilead common stock is traded on The Nasdaq Stock Market under the symbol GILD. CONTACT: Gilead Sciences, Inc. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion